Published August 18, 2025
| Version v1
Journal article
Open
De-escalated Teclistamab dosing in relapsed/refractory multiple myeloma: Czech myeloma group real-world evidence analysis
Authors/Creators
-
Stork, Martin
-
Radocha, Jakub1
-
Mihalyova, Jana
-
Spicka, Ivan2
-
Pika, Tomáš3
-
Jungová, Alexandra
- Boichuk, Ivanna4
- Mensikova, Klara5
- Jan, Straub2
-
Sedlak, Frantisek6
-
Minarik, Jiri7, 8
-
Krhovska, Petra3
- Nováková, Denisa1
- Hornakova, Michaela9, 10
- Zdenka, Knechtova4
- Sendlerova, Nela4
- Dekojova, Tereza11
-
Maisnar, Vladimir
-
Jelinek, Tomas12, 13
-
Hajek, Roman9, 10
- Pour, Luděk4
-
1.
University Hospital Hradec Králové
-
2.
Charles University
- 3. Lékařská Fakulta Univerzita Palackého v Olomouci
-
4.
University Hospital Brno
- 5. university hospital brno
- 6. Charles University, First Faculty of Medicine & General University Hospital
-
7.
University Hospital Olomouc
-
8.
Palacký University Olomouc
-
9.
University Hospital Ostrava
-
10.
University of Ostrava
- 11. charles university hospital, pilsen
- 12. Clinica Universidad de Navarra
- 13. university hospital ostrava
Description
Publication type: Journal Article (J) - Article
This article was published in Annals of Hematology and licensed under CC-BY 4,0.
Files
Teclistamab_Ann_Hematol.pdf
Files
(808.1 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:cadc4428fbdbc00c3e3e9722b5fdc4b4
|
808.1 kB | Preview Download |
Additional details
Funding
- Ministry of Education Youth and Sports
- SALVAGE project CZ.02.01.01/00/22_008/0004644
Dates
- Accepted
-
2025-07-21